This was the stock's second consecutive day of losses.

Bristol-Myers Squibb has rebounded strongly in 2024, driven by key drug approvals and positive financial performance. See why ...

We recently compiled a list of the Long-Term Stock Portfolio: Best Stocks for 10 Years. In this article, we are going to take ...

All traffic has been stopped on the M5 after a crash near Bristol this evening (Monday, December 30). The collision took ...

BRISTOL, Va. (WDBJ) - Fire crews were called back to the former Virginia Intermont College campus in Bristol this past ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Zolacabtagene autoleucel is under clinical development by Bristol-Myers Squibb and currently in Phase I for Follicular Lymphoma.

IL2-CD25 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Autoimmune Disorders.

During the summer transfer window, Bristol Rovers completed the significant addition of Walsall playmaker Isaac Hutchinson, ...

BRISTOL, TENN. (WCYB) — The signs are up for a new restaurant in Bristol, Tennessee. Work is underway for a Cook Out ...

Bristol City welcome Portsmouth to Ashton Gate on Sunday with the visitors hoping to repeat the score line from the two teams ...